Management of Treatment‐Resistant Dermatitis Herpetiformis With Tofacitinib: A Case Report
Tofacitinib may offer a safe and effective treatment alternative for patients with dermatitis herpetiformis unresponsive to dapsone and a gluten-free diet, highlighting the potential role of JAK inhibition in refractory autoimmune skin diseases.
Authors
- Mohammad Malekan (ORCID: https://orcid.org/0000-0002-5622-0294)
- Fatemeh Montazer (ORCID: https://orcid.org/0000-0002-4487-1399)
- Armaghan Kazeminejad (ORCID: https://orcid.org/0000-0002-3870-0382)
Institutions
- Iran University of Medical Sciences (IR)
- Mazandaran University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/ccr3.71410
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00